1. 1. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). E14 Guidance on Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythic Potential for Non-antiarrythmic Drugs. Available at: http://www.fda.gov/cder/guidance/6922fnl.pdf, 2005.
2. Digital 12-lead Holter in the assessment of drug effects on cardiac repolarization;Sarapa;J Electrocardiol,2006
3. QT interval analysis on ambulatory recordings: A selective beat averaging approach;Badilini;Med Bio EngComp,1999
4. Control of rapid heart rate changes for electrocardiographic analysis: Implications for thorough QT studies;Extramiana;Clin Cardiol,2006
5. The ISHNE Holter sandard output file format;Badilini;Ann Noninvasive Electrocardiol,1998